AKT1 and lung cancer: Studies have found that TLR9 can promote the progression of lung cancer [13], and miR-7 can inhibit the growth and metastasis of lung cancer cells by regulating the PIK3R3/Akt pathway and inhibiting the TLR9 signaling pathway [14].